Bortezomib (2 mg)

admin — Wed, 18 Feb 2026 10:55:12 +0000

Overview: Arsenox 10 mg Injection contains Arsenic Trioxide (10 mg) and is a prescription antineoplastic medicine used in the treatment of acute promyelocytic leukemia (APL) by inducing apoptosis and promoting differentiation of leukemia cells. Key Benefits: – Effective targeted therapy for APL – Helps induce cancer cell death and differentiation – Administered under clinical supervision Composition: Arsenic Trioxide (10 mg) How It Works: Arsenic Trioxide works by inducing apoptosis (programmed cell death) and promoting differentiation of malignant promyelocytic leukemia cells, leading to reduced tumor burden and improved disease control. Usage Instructions: – Administer only under the supervision of qualified healthcare professionals – Dosage and schedule determined by oncologist based on patient condition – Not for self-administration Side Effects: – Nausea, vomiting, fatigue – QT interval prolongation, electrolyte imbalance – Headache, fever Precautions: – Monitor cardiac function, electrolytes and blood counts regularly during treatment – Not recommended during pregnancy or breastfeeding unless advised by a physician – Inform your doctor of all current medications Storage Instructions: – Store below 25°C, protect from light, do not freeze Manufacturer: Generic Pharmaceuticals Disclaimer: To be sold by retail on the prescription of a registered medical practitioner only.

APL cancer treatment – Globalstar International

Bortezomib (2 mg)